Emulate launches unique high-throughput organ-chip platform June 16, 2025July 9, 2025 Share More from the Blog Charting Our Path Forward: Determination and Resilience Attracts $82M Series E Funding Read More Insights into the AVA™ Emulation System: Ushering in a New Era of Human-Relevant Drug Discovery Read More ChipChat: What is a “Big Toe-on-a-Chip”? Exploring the Endless Possibilities of Organ-Chips with Emulate Chief Scientific Officer Lorna Ewart, PhD Read More Browse All